Walleye Trading’s Rocket Pharmaceuticals Warrant RCKTW Stock Holding History

Walleye Trading’s Portfolio RCKTW Stock Details RCKTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-63,391	Closed	-$2.5K	–	4743
2025 Q2	$2.5K	Sell	63,391 -20,600	-25%	-$857	﹤0.01%	4124
2025 Q1	$3.95K	Hold	83,991	–	–	﹤0.01%	3903
2024 Q4	$2.88K	Buy	83,991 +49,162	+141%	+$2.4K	﹤0.01%	4109
2024 Q3	$2.44K	Hold	34,829	–	–	﹤0.01%	3907
2024 Q2	$2.11K	Hold	34,829	–	–	﹤0.01%	4059
2024 Q1	$10.4K	Hold	34,829	–	–	﹤0.01%	4311
2023 Q4	$17.1K	Hold	34,829	–	–	﹤0.01%	4534
2023 Q3	$5.92K	Hold	34,829	–	–	﹤0.01%	4607
2023 Q2	$6.62K	Hold	34,829	–	–	﹤0.01%	4314
2023 Q1	$1.92K	Buy	+34,829	New	+$6.72K	﹤0.01%	4649

Other funds holding RCKTW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Walleye Trading's RCKTW Position: Q3 2025 in Review

Walleye Trading sold out of Rocket Pharmaceuticals Warrant (RCKTW) in Q3 2025, closing a stake of 63,391 shares — an estimated $2.5K sold.

Walleye Trading first reported a position in RCKTW in Q1 2023 and held it in 10 quarters. The position peaked at $17.1K in Q4 2023. 11 funds tracked by Wall St. Rank hold RCKTW as of Q3 2025.

Walleye Trading reported no remaining Rocket Pharmaceuticals Warrant position as of Q3 2025 after selling out during the quarter.
Walleye Trading sold 63,391 Rocket Pharmaceuticals Warrant shares in Q3 2025, an estimated $2.5K.
Walleye Trading first reported a position in Rocket Pharmaceuticals Warrant in Q1 2023 and held it in 10 quarters.
Walleye Trading's Rocket Pharmaceuticals Warrant position peaked at $17.1K in Q4 2023.
11 funds tracked by Wall St. Rank held Rocket Pharmaceuticals Warrant as of Q3 2025.

Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.